{
    "nct_id": "NCT05714657",
    "official_title": "A Phase II Study of Shortened Course, Dose De-Intensified Adjuvant Radiotherapy Following Transoral Robotic Surgery (TORS) and Neck Dissection for HPV-Associated Oropharyngeal Squamous Cell Carcinoma",
    "inclusion_criteria": "* Patients ≥ 18 years old\n* Histologically confirmed diagnosis of squamous cell carcinoma of the oropharynx, p16-positive on immunohistochemistry or HPV-positive by In-Situ Hybridization\n* Pathologic T0 (unknown primary), T1, T2, or T3 disease (per AJCC 8th Ed)\n* Pathologic N0-N1 disease (per AJCC 8th Ed)\n* Preoperative plasma ctHPVDNA of ≥ 50 copies/mL\n* Undetectable postoperative plasma ctHPVDNA\n* ECOG Performance Status 0-1\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior external beam radiation therapy to the head and neck\n* Presence of T4 disease\n* ≥ 5 positive lymph nodes (which is pathologic N2 disease, per AJCC 8th edition)\n* Presence of distant metastatic disease\n* Uncontrolled inter-current illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, connective tissue disease or psychiatric illness/social situations that would limit compliance with study requirements.",
    "miscellaneous_criteria": ""
}